Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Both steroids effectively promote hair growth for at least 9 months.

Both treatments work equally well for hair regrowth, but the lotion has fewer side effects.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

Promising cancer treatments were found, but the manufacturer closed.

Gefitinib can cause rare scarring hair loss.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

ATP helps prevent skin damage from vandetanib by reducing stress.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.